ADAPTIVE BIOTECHNOLOGIES CORPORATION Payments for Restructuring
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Payments for Restructuring of $2.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2025-03-03
- ADAPTIVE BIOTECHNOLOGIES CORPORATION payments for restructuring for the quarter ending 2022-06-30 was $600.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION payments for restructuring for the quarter ending 2022-03-31 was $1.40M.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION payments for restructuring for fiscal 2022 was $2.00M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2022-12-31 | $2.00M 10-K · filed 2025-03-03 | ||
| 2022-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | $2.00M 10-Q · filed 2022-11-03 | |
| 2022-03-31 | $1.40M 10-Q · filed 2022-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |